Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Change in Accured Expenses (2016 - 2026)

Wave Life Sciences filings provide 12 years of Change in Accured Expenses readings, the most recent being -$13.5 million for Q1 2026.

  • On a quarterly basis, Change in Accured Expenses fell 1.91% to -$13.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $5.2 million, a 338.76% increase, with the full-year FY2025 number at $5.5 million, up 28.92% from a year prior.
  • Change in Accured Expenses hit -$13.5 million in Q1 2026 for Wave Life Sciences, down from $10.1 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $10.1 million in Q4 2025 to a low of -$13.5 million in Q1 2026.
  • Median Change in Accured Expenses over the past 5 years was $3.5 million (2025), compared with a mean of -$106941.2.
  • Biggest five-year swings in Change in Accured Expenses: plummeted 102.01% in 2022 and later soared 7668.97% in 2023.
  • Wave Life Sciences' Change in Accured Expenses stood at $6.5 million in 2022, then plummeted by 35.28% to $4.2 million in 2023, then soared by 65.06% to $6.9 million in 2024, then skyrocketed by 45.22% to $10.1 million in 2025, then plummeted by 234.18% to -$13.5 million in 2026.
  • The last three reported values for Change in Accured Expenses were -$13.5 million (Q1 2026), $10.1 million (Q4 2025), and $3.5 million (Q3 2025) per Business Quant data.